Company Profile

Company Overview

About The University of Kansas Hospital:
Recognized as one of the top hospitals in the United States by U.S. News & World Report, The University of Kansas Hospital is a 1045-bed academic medical center and Level 1 trauma center, with a mission to lead in the discovery of new knowledge, deliver outstanding patient care in this region and beyond, and educate the healthcare professionals of tomorrow. The Health System, consistently earning national recognition for outstanding quality and safety in several medical specialties, is known for its Center for Advanced Heart Care, Center for Transplantation, Advanced Comprehensive Stroke Center, and NCI-designated Comprehensive Cancer Center. Magnet designation is proof of our hard-earned commitment to nursing excellence.

About University of Kansas Cancer Center:
The University of Kansas Cancer Center is an NCI-designated Comprehensive Cancer Center and plans are underway to construct a new $550 million state-of-the-art new cancer center building. The Department of Radiation Oncology provides cancer care services throughout the Kansas City metropolitan area with over 4,500 treatment courses annually and 300 patients on treatment daily. Our primary network includes 7 locations with 11 Varian linear accelerators including TrueBeam, Edge and Ethos. The Department has recently completed a Varian ARIA/Eclipse v18.0 upgrade, the first in the US, and maintains a close relationship with Varian, IBA, and other equipment vendors providing unique opportunities for collaboration. The Department of Radiation Oncology is one of a dozen ABS fellowship training sites for both HDR and LDR brachytherapy for prostate and gynecological cancer. The University of Kansas Proton Center is equipped with a state-of-the-art IBA ProteusONE compact proton therapy system, a RayStation v2023B treatment planning system, and an SDX respiratory gating system that are integrated within Varian’s ARIA V18.0, the first ProteusONE center doing so in the world. The system is LATTICE, FLASH, and minibeam capable. Since our proton center opened in May 2022, we have successfully treated more than six hundred patients. The Proton Center is a founding member of the Conformal Flash Alliance and there is an ongoing research agreement with IBA for its preclinical validation and clinical implementation.